O’Melveny’s Biotechnology Group works with the full spectrum of life sciences market participants—innovative start-ups, sophisticated investors, multi-billion dollar publicly traded companies, investment bankers, and research institutions, universities, and incubators—to drive growth in the competitive global marketplace.
Many of our lawyers hold advanced degrees in molecular biology, chemistry, microbiology, and other relevant fields of study. We are able to integrate sector-specific capabilities in corporate, intellectual property, employment and trade secrets, securities and finance, commercial litigation, products liability, and federal and state regulatory law to support the successful commercialization of novel applications of the biological sciences.
Our team features lawyers resident in key scientific and commercial centers around the world, including in China’s burgeoning biotechnology market and in the startup- and venture capital-driven Silicon Valley. This immersion in the diverse business communities in which we work gives us the global reach to support our clients in their efforts to expand and exploit opportunities on a transnational basis, and the familiarity with local industry players and business practices to ensure the success of cross-border undertakings.
For more information, visit our Capital Markets
, Intellectual Property & Technology
, Mergers & Acquisitions
, Products Liability
, and Venture Capital and Emerging Technologies